jrnls.org logo
Submit

BROWSE ALL JOURNALS

SEE ALL 19 JOURNALS
Indian Journal of Pharmaceutical Education and ResearchNOW IN
Article

Neuroprotective Effects of Conessine in Beta-Amyloid- Induced SH-SY5Y Cells In vitro

Dandan Zhang1, Jun Wu2★, Amirah Albaqami3, Wedad Mawkili4, Faten F. Bin Dayel5, Tahera Waheed Alnassfan6★ Corresponding author

  1. 1Department of Geriatrics, The First Affiliated Hospital of Xi ‘an Jiaotong University, Xi’an, CHINA.
  2. 2Department of Neurological Rehabilitation, Xi ‘an International Medical Center Hospital, Xi’an, CHINA.
  3. 3Department of Clinical Laboratory Sciences, Turabah University College, Taif University, Taif, SAUDI ARABIA.
  4. 4Department of Pharmacology and Toxicology, College of Pharmacy, Jazan University, Jazan, SAUDI ARABIA.
  5. 5Department of Pharmacology and Toxicology, College of Pharmacy, Prince Sattam Bin Abdulaziz University, Al-Kharj, SAUDI ARABIA.
  6. 6Department of Public Health, College of Applied Medical Sciences in Al-Namas, University of Bisha, Bisha, SAUDI ARABIA.

CORRESPONDENCE

Jun Wu

Department of Neurological Rehabilitation, Xi ‘an International Medical Center Hospital, Xi’an, CHINA.

june_wu666@sina.com

Received: 29-12-2025; Revised: 09-02-2026; Accepted: 17-04-2026.

Volume 60, Issue 3 · pp. 1180–1188 · PUBLISHED 2026 · DOI: 10.5530/ijper.20263491

View on IJPER original site ↗

ABSTRACT

Objectives: Alzheimer’s Disease (AD) is a brain disorder that affects the memory and thinking ability of the patient, characterised by beta-amyloid (Aβ) plaque accumulation, oxidative stress, impaired autophagy, and neuronal death, leading to cognitive decline. Current treatment for AD is limited to symptomatic relief, which highlights the demand for the discovery of newer drugs. Conessine, a steroidal alkaloid derived from Holarrhena antidysenterica, has demonstrated potential neuroprotective activity; however, its mechanism of action against beta-amyloidinduced toxicity remains unclear. Materials and Methods: In this study, we examined the protective effect of conessine on neurons in SH-SY5Y human neuroblastoma cells. MTT assay was used to study the general toxicity profile and the neuroprotective function of conessine. The level of autophagy was determined through flow cytometry analysis. The level of ROS generated in cells during beta-amyloid treatment was quantified using a fluorescence-based assay. Oxidative stress gene expression was analysed using real-time PCR experiments. Results: The results suggest that conessine at low doses (≤12.5 μg/mL) protects cells from beta-amyloid-induced cytotoxicity and restores their viability and shape. Flow cytometry showed that conessine (12.5 μg/mL) increased autophagy. In addition, DCFDA staining revealed that conessine reduced the production of Reactive Oxygen Species (ROS) induced by amyloid beta. Real-time PCR showed that conessine increased the expression of the antioxidant genes NRF2 and HMOX1 in Aβ-treated cells by 1.5 and 1.10 times, respectively, and even more in cells that were only treated with conessine (1.78 and 1.4 times). Conclusion: Collectively, these results suggest that conessine has potential as a therapeutic candidate for AD. More research is thus warranted to elucidate its molecular interactions and clinical applicability.

KEYWORDS

Open in new tab

REFERENCES

As published

Showing references and in-text citations exactly as published.

    Cite this article

    SELECT FORMAT

    Zhang, D., Wu, J., Albaqami, A., Mawkili, W., Dayel, F. F. B., & Alnassfan, T. W. (2026). Neuroprotective Effects of Conessine in Beta-Amyloid- Induced SH-SY5Y Cells In vitro. Indian Journal of Pharmaceutical Education and Research, 60(3), 1180–1188. https://doi.org/10.5530/ijper.20263491